Solution
You are here: Home » News » Solution
LATEST NEWS
July 08, 2025

Inflammatory Bowel Disease (IBD) has emerged as a significant area of medical research, and understanding the molecular pathways that drive it is crucial for developing effective treatments.

July 03, 2025

Inflammatory Bowel Disease (IBD) is a chronic condition affecting millions worldwide, characterized by inflammation of the gastrointestinal tract.

June 30, 2025

Inflammatory Bowel Disease (IBD) is a chronic condition that affects millions of people worldwide.

June 27, 2025

Inflammatory Bowel Disease (IBD) remains a significant area of study in immunology and gastroenterology.

June 16, 2025

Inflammatory Bowel Disease (IBD) has become a major global health concern, characterized by chronic inflammation of the gastrointestinal tract.

May 26, 2025

Colitis, a common and often debilitating condition within the spectrum of Inflammatory Bowel Disease (IBD), affects millions of people worldwide. Researchers and healthcare professionals are continually seeking new methods for better understanding, diagnosing, and treating this chronic disease. One key to unlocking improved therapeutic strategies is the development and use of the IBD Model.

HKeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to the fields of autoimmune and allergic diseases. 

CONTACT US

Phone: +1 2396821165
Email:  tech@hkeybio.com
Add: Boston site 「134 Coolidge Ave, Suite 2, Watertown, MA 02472」
China site「Room 205, Building B, Ascendas iHub Suzhou, Singapore Industrial Park, Jiangsu」

QUICK LINKS

PRODUCTS CATEGORY

SIGN UP FOR OUR NEWSLETTER

Copyright © 2026 HkeyBio. All Rights Reserved.  Sitemap | Privacy Policy